Article
Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study.
International journal of molecular sciences - 28 Nov 2020
Lopez Susanna, Del Percio Claudio, Forloni Gianluigi, Frasca Angelisa, Drinkenburg Wilhelmus H, Lizio Roberta, Noce Giuseppe, Ferri Raffaele, Soricelli Andrea, Stocchi Fabrizio, Vacca Laura, Bordet Règis, Richardson Jill C, Babiloni Claudio
Abstract excerpt
OBJECTIVE: In this exploratory study, we tested whether electroencephalographic (EEG) rhythms may reflect the effects of a chronic administration (4 weeks) of an anti-amyloid β-site amyloid precursor protein (APP) cleaving enzyme 1 inhibitor (BACE-1; ER-901356; Eisai Co., Ltd., Tokyo, Japan) in TASTPM (double mutation in APP KM670/671NL and PSEN1 M146V) producing Alzheimer's disease (AD) amyloid neuropathology as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
